Top Suppliers:I want be here

  • DC Chemicals Limited
  • China
  • Product Name: MNS
  • Price: $Inquiry/100mg $Inquiry/250mg $Inquiry/1g
  • Purity: 98.0%
  • Stocking Period: 3 Day
  • Contact: Tony Cao


1485-00-3

1485-00-3 structure
1485-00-3 structure
  • Name: MDBN
  • Chemical Name: 3,4-Methylenedioxy-beta-nitrostyrene
  • CAS Number: 1485-00-3
  • Molecular Formula: C9H7NO4
  • Molecular Weight: 193.156
  • Catalog: Chemical reagent Organic reagent Olefins (cyclic and non-cyclic)
  • Create Date: 2018-10-12 15:51:39
  • Modify Date: 2024-01-02 18:32:22
  • MNS is a potent and selective inhibitor of Src and Syk tyrosine kinases. target: src, syk. [1]IC50:29.3 (src), 2.5 uM (syk); [1]In vitro: no direct effects on protein kinase C, Ca2+ mobilization, Ca2+-dependent enzymes, PKC activation. MNS potently prevents GPIIb/IIIa activation and platelet aggregation without directly affecting other signaling pathways required for platelet activation. [1] [2] MNS is much more potent than genistein in inhibiting platelet aggregation and protein tyrosine phosphorylation. [2]

Name 3,4-Methylenedioxy-beta-nitrostyrene
Synonyms 1,3-Benzodioxole, 5- (2-nitroethenyl)-
3,4-Methylenedioxy-β-nitrostyrene
5-[(E)-2-Nitrovinyl]-1,3-benzodioxole
1,3-Benzodioxole, 5-[(E)-2-nitroethenyl]-
T56 BO DO CHJ G1U1NW
MFCD00014575
5-(2-Nitrovinyl)benzo[d][1,3]dioxole
MNS
Description MNS is a potent and selective inhibitor of Src and Syk tyrosine kinases. target: src, syk. [1]IC50:29.3 (src), 2.5 uM (syk); [1]In vitro: no direct effects on protein kinase C, Ca2+ mobilization, Ca2+-dependent enzymes, PKC activation. MNS potently prevents GPIIb/IIIa activation and platelet aggregation without directly affecting other signaling pathways required for platelet activation. [1] [2] MNS is much more potent than genistein in inhibiting platelet aggregation and protein tyrosine phosphorylation. [2]
Related Catalog
References

[1]. Wang WY et al. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosinekinase inhibitor. Mol Pharmacol. 2006 Oct;70(4):1380-9.

[2]. Wang WY et al. Synthesis and pharmacological evaluation of novel beta-nitrostyrene derivatives as tyrosine kinase inhibitorswith potent antiplatelet activity. Biochem Pharmacol. 2007 Aug 15;74(4):601-11.

Density 1.4±0.1 g/cm3
Boiling Point 334.9±11.0 °C at 760 mmHg
Melting Point 159-163 °C
Molecular Formula C9H7NO4
Molecular Weight 193.156
Flash Point 168.8±21.3 °C
Exact Mass 193.037506
PSA 64.28000
LogP 2.27
Vapour Pressure 0.0±0.7 mmHg at 25°C
Index of Refraction 1.640
Storage condition Store at +4°C

CHEMICAL IDENTIFICATION

RTECS NUMBER :
WL5270000
CHEMICAL NAME :
Styrene, 3,4-methylenedioxy-beta-nitro-
CAS REGISTRY NUMBER :
1485-00-3
BEILSTEIN REFERENCE NO. :
0192350
LAST UPDATED :
199612
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C9-H7-N-O4
MOLECULAR WEIGHT :
193.17
WISWESSER LINE NOTATION :
T56 BO DO CHJ G1U1NW

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD - Lethal dose
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
CBCCT* "Summary Tables of Biological Tests," National Research Council Chemical-Biological Coordination Center. (National Academy of Science Library, 2101 Constitution Ave., NW, Washington, DC 20418) Volume(issue)/page/year: 6,375,1954
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
32 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
CSLNX* U.S. Army Armament Research & Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals. (Aberdeen Proving Ground, MD 21010) Volume(issue)/page/year: NX#00689
Hazard Codes Xn:Harmful;
Risk Phrases R22;R36/37/38
Safety Phrases S36/37/39-S26-S45
RIDADR UN 2811 6.1/PG 3
RTECS WL5270000
HS Code 2932999099

~99%

1485-00-3 structure

1485-00-3

Literature: McNulty, James; Steere, Jennifer A.; Wolf, Sonja Tetrahedron Letters, 1998 , vol. 39, # 44 p. 8013 - 8016

~87%

1485-00-3 structure

1485-00-3

Literature: Manna, Srimanta; Jana, Sandipan; Saboo, Tapish; Maji, Arun; Maiti, Debabrata Chemical Communications, 2013 , vol. 49, # 46 p. 5286 - 5288

~80%

1485-00-3 structure

1485-00-3

Literature: Abbott Laboratories Patent: US6162927 A1, 2000 ; US 6162927 A

~71%

1485-00-3 structure

1485-00-3

Literature: Hirao, Haruna; Yamauchi, Satoshi; Ishibashi, Fumio Bioscience, Biotechnology and Biochemistry, 2007 , vol. 71, # 3 p. 741 - 745

~31%

1485-00-3 structure

1485-00-3

Literature: Research on Chemical Intermediates, , vol. 39, # 8 p. 3715 - 3725
HS Code 2932999099
Summary 2932999099. other heterocyclic compounds with oxygen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%